Miroslava Kouzmova-Moneva

Endocrinology in Indianapolis, Indiana

Practice Details

Address
5230 E Stop 11 Rd Ste 150
Indianapolis, IN 46237
Geocoded location: 39.6513, -86.0795
Taxonomy
Endocrinology, Diabetes & Metabolism
Credential
M.D.
NPPES Enumeration
Listed with NPPES since 2006
Sole Proprietor
No
Provider Gender (NPPES)
Female
NPPES Record Updated
May 2023

Specialty taxonomies on file (2)

  • Internal Medicine
  • Endocrinology
    Internal Medicine, Endocrinology, Diabetes & Metabolism
    Primary

All specialty taxonomies this NPI reports in the CMS National Provider registry. A taxonomy on file reflects a self-reported designation, not confirmation of current services.

About This Clinician

This clinician is enumerated under Endocrinology, Diabetes & Metabolism. Endocrinologists treat hormonal and metabolic conditions including type 2 diabetes, and frequently prescribe GLP-1 medications such as semaglutide or tirzepatide as part of diabetes or metabolic-syndrome management — though not every endocrinology practice treats obesity as a primary focus, and some see only referred, complex cases.

Locally, this is 1 of 71 Endocrinology, Diabetes & Metabolism practices in Indianapolis carrying this exact taxonomy in our directory.

What to expect at an Endocrinology visit

Endocrinology visits focus on hormonal and metabolic conditions. For a GLP-1-related consult, patients commonly encounter:

  • •A review of diabetes, thyroid, or metabolic history and current medications.
  • •Lab work such as A1c and a metabolic panel to guide diagnosis and dosing.
  • •A discussion of whether a GLP-1 medication fits the treatment goal (diabetes control, weight, or both).
  • •Follow-up scheduling to titrate dose and monitor response over time.

This is general guidance for endocrinology practices, not a description of Miroslava Kouzmova-Moneva's specific protocol, services, or pricing. Confirm what a visit involves directly with the practice — 317-865-5904.

GLP-1 access in Indianapolis, Indiana

Adult obesity rate
36.4%
#9 of 50 states (CDC BRFSS)
Avg. compounded semaglutide
$189/mo
Typical Indiana telehealth cash price
Medicaid GLP-1 coverage
Diabetes only
Indiana Medicaid, obesity indication

About 36.4% of Indiana adults have obesity (BMI 30+), ranking the state #9 of 50 (CDC BRFSS). Our directory currently lists 125 GLP-1-relevant clinics in Indianapolis. If a cash-pay route makes more sense, compounded semaglutide through Indiana telehealth averages about $189/mo — well below brand-name Wegovy or Zepbound.

Explore more Indiana options on the best Indiana GLP-1 providers page, browse every Indianapolis listing in the Indianapolis clinic directory, or read the Indiana Medicaid GLP-1 coverage & prior-authorization guide.

Related Practices in Indianapolis

Other Indianapolis listings in the same directory tier:

Michael Waddell
Endocrinology
Moazzam Habib
Endocrinology
Michael Hancock
Endocrinology

Telehealth Alternative

Prefer not to visit in person? Licensed GLP-1 telehealth providers ship compounded semaglutide or tirzepatide directly to Indiana addresses, often faster and at lower cash cost than an in-person visit and brand-name prescription. Featured Indiana telehealth partners:

Featured Partners · Indianapolis

Featured GLP-1 providers serving Indianapolis

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

  1. Top pick
    7.6
    Maximus

    Compounded from

    $249.99/mo

    Save $1,099.01/mo vs Wegovy
    Get started →
  2. 8.3
    Found

    Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  3. 7.4
    Breeze Meds

    Compounded from

    $199/mo

    Save $1,150/mo vs Wegovy
    Get started →
  4. 6.2
    Wellorithm

    Compounded from

    $147/mo

    Save $1,202/mo vs Wegovy
    Get started →
  5. 8.2
    Gala

    Compounded from

    $149/mo

    Save $937/mo vs Zepbound
    Get started →
  6. 6.9
    TMates

    Compounded from

    $249/mo

    Save $1,100/mo vs Wegovy
    Get started →
See all 171 GLP-1 providers serving Indianapolis ↓

See more Indianapolis options on the Indianapolis clinic directory, our Indianapolis GLP-1 telehealth page, or compare the best semaglutide providers nationwide.

Learn more about the medications most commonly prescribed by Indianapolis obesity-medicine and endocrinology practices: Semaglutide and Tirzepatide.

Frequently Asked Questions

The CMS National Provider registry lists Miroslava Kouzmova-Moneva's specialty taxonomy but not the specific medications it prescribes or its current service menu. Miroslava Kouzmova-Moneva is listed under Endocrinology, a field where GLP-1 medications such as semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro) are commonly prescribed — but whether this practice currently offers them isn't recorded in the registry. Call the practice at 317-865-5904 to confirm before booking.
According to its CMS National Provider registry (NPPES) record, Miroslava Kouzmova-Moneva's primary specialty on file is Endocrinology.
Miroslava Kouzmova-Moneva is located at 5230 E Stop 11 Rd Ste 150, Indianapolis, IN 46237. The phone number listed in the registry is 317-865-5904. Its full record is public in the CMS National Provider registry under NPI 1649246844.
New-patient status isn't recorded in the CMS National Provider registry, so we can't confirm whether Miroslava Kouzmova-Moneva is currently accepting new patients. Call the practice at 317-865-5904 to confirm availability, cash-pay pricing, and whether the services you need are offered — this listing reflects the NPPES taxonomy on file and is not an endorsement.